Icon

PARAPLATIN (nda019880)- (50MG/VIAL,150MG/VIAL,450MG/VIAL)

CARBOPLATIN CORDEN PHARMA
50MG/VIAL,150MG/VIAL,450MG/VIAL
Yes No
2004-Oct-14 Expired
None None
None No
PARAPLATIN (carboplatin) Injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. PARAPLATIN is indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin.
0 0 0
Total Other Developers None
Drugs with Suitability No
50MG/VIAL ** ** - - -
150MG/VIAL ** ** - - -
450MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.